Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists watch sepsis damage tiny vessels in real time

NCT ID NCT07404475

First seen Feb 16, 2026 · Last updated Jun 19, 2026 · Updated 26 times

Summary

This completed study looked at 30 adults with sepsis to understand how changes in tiny blood vessels (microcirculation) relate to blood clotting problems. Researchers used a special microscope to view blood vessels under the tongue and measured clotting factors. The goal was to see if patients with clotting issues had worse vessel damage. No treatments were given; this was purely an observation study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Azienda Ospedaliero Universitaria delle Marche

    Ancona, 60126, Italy

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better understand how sepsis damages small blood vessels and causes clotting issues, potentially guiding future treatments.

What could go wrong

This is a small, observational study with only 30 participants. It does not test any treatment, so it cannot directly improve patient care. Results may not apply to all sepsis patients.

Conditions

The condition(s) this trial relates to.

blood coagulation disease infectious disease with sepsis Sepsis vascular hemostatic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.